Your browser doesn't support javascript.
loading
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon.
Valkema, Maria J; Spaander, Manon C W; Boonstra, Jurjen J; van Dieren, Jolanda M; Hazen, Wouter L; Erkelens, G Willemien; Holster, I Lisanne; van der Linden, Andries; van der Linde, Klaas; Oostenbrug, Liekele E; Quispel, Rutger; Schoon, Erik J; Siersema, Peter D; Doukas, Michail; Eyck, Ben M; van der Wilk, Berend J; van der Sluis, Pieter C; Wijnhoven, Bas P L; Lagarde, Sjoerd M; van Lanschot, J Jan B.
Afiliação
  • Valkema MJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Boonstra JJ; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
  • van Dieren JM; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hazen WL; Department of Gastroenterology, Elisabeth Tweesteden Hospital, Tilburg, The Netherlands.
  • Erkelens GW; Department of Gastroenterology, Gelre Hospital, Apeldoorn, The Netherlands.
  • Holster IL; Department of Gastroenterology, Maasstad Hospital, Rotterdam, The Netherlands.
  • van der Linden A; Department of Gastroenterology, Zorggroep Twente, Almelo, The Netherlands.
  • van der Linde K; Department of Gastroenterology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
  • Oostenbrug LE; Department of Gastroenterology and Hepatology, Zuyderland Medical Centre, Heerlen, The Netherlands.
  • Quispel R; Department of Gastroenterology and Hepatology, Reinier de Graaf Group, Delft, The Netherlands.
  • Schoon EJ; Department of Gastroenterology and Hepatology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
  • Siersema PD; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • Doukas M; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Eyck BM; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van der Wilk BJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van der Sluis PC; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Wijnhoven BPL; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Lagarde SM; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Lanschot JJB; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Br J Surg ; 110(10): 1381-1386, 2023 09 06.
Article em En | MEDLINE | ID: mdl-37418342
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Transtornos de Deglutição Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Br J Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Transtornos de Deglutição Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Br J Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda